Clinical trials: Sea Sickness
Motion Sickness, Space, Motion Sickness
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
The primary specific aim is to evaluate the use of intranasal scopolamine gel and sensory augmentation as an integrated countermeasure to mitigate motion sickness and enhance sensorimotor performance.
- Conditions
- Motion Sickness, Space, Motion Sickness, Sea Sickness
- Trial name
- NCT05886660
- Testing
- DPI-386 Nasal Gel
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Repurposed Therapeutics, Inc.
Sea Sickness
Video Head Impulse Test and Seasickness Susceptibility
This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score.
- Trial name
- NCT05657340
- Testing
- Video-head impulse testing
- Where
- Israel
- Volunteers
- 86 people, healthy volunteers welcome
- Sponsor
- Medical Corps, Israel Defense Force
Sea Sickness
Motion Sickness on Astrolabe's Vessel
Sea sickness syndrome is present for 80% of persons on board when the boat rotation missions Astrolabe, sometimes there is a risk of very significant dehydration.
- Trial name
- SICKVEST (NCT02911402)
- Testing
- sea sickness questionnaires
- Where
- France
- Volunteers
- 147 people, healthy volunteers welcome
- Sponsor
- University Hospital, Caen